abstract |
REFERS TO A COMBINATION THAT INCLUDES: a) S- [2 - ({[1- (2-ETHYLBUTYL) CYCLOHEXYL] CARBONYL} AMINO) PHENYL 2-METHYLPROPANTIOATE] OR A S- [2 - ({[ 1- (2-ETHYLBUTYL) CYCLOHEXIL] CARBONYL} AMINO) PHENYL] THIOL in vivo AND b) AN INHIBITOR OF HMG COA REDUCTASE SELECTED FROM ATORVASTATIN, PRAVASTATIN, FLUVASTATIN, SIMVASTATIN, LOVASTATIN, AMONG OTHERS. ALSO INCLUDES ONE OR MORE PHARMACEUTICALLY ACCEPTABLE VEHICLES. THE COMBINATION IS USEFUL FOR THE TREATMENT AND PROPHYLAXIS OF A CARDIOVASCULAR DISORDER |